-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on AbbVie, Raises Price Target to $340

Benzinga·11/02/2026 13:49:53
Listen to the news
Wells Fargo analyst Mohit Bansal maintains AbbVie (NYSE:ABBV) with a Overweight and raises the price target from $300 to $340.